Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma

The New England Journal of Medicine
Parameswaran NairZONDA Trial Investigators

Abstract

Many patients with severe asthma rely on oral glucocorticoids to manage their disease. We investigated whether benralizumab, a monoclonal antibody directed against the alpha subunit of the interleukin-5 receptor that significantly reduces the incidence of asthma exacerbations, was also effective as an oral glucocorticoid-sparing therapy in patients relying on oral glucocorticoids to manage severe asthma associated with eosinophilia. In a 28-week randomized, controlled trial, we assessed the effects of benralizumab (at a dose of 30 mg administered subcutaneously either every 4 weeks or every 8 weeks [with the first three doses administered every 4 weeks]) versus placebo on the reduction in the oral glucocorticoid dose while asthma control was maintained in adult patients with severe asthma. The primary end point was the percentage change in the oral glucocorticoid dose from baseline to week 28. Annual asthma exacerbation rates, lung function, symptoms, and safety were assessed. Of 369 patients enrolled, 220 underwent randomization and started receiving benralizumab or placebo. The two benralizumab dosing regimens significantly reduced the median final oral glucocorticoid doses from baseline by 75%, as compared with a reduction o...Continue Reading

References

Jun 3, 2000·The European Respiratory Journal·M M PizzichiniF E Hargreave
Sep 11, 2003·Annals of Internal Medicine·Peter J Barnes, Ian M Adcock
Apr 13, 2005·Respiratory Medicine·Elizabeth F JuniperElisabeth Ståhl
Sep 20, 2005·Health and Quality of Life Outcomes·Elizabeth F JuniperElisabeth Ståhl
Feb 13, 2007·The Journal of Allergy and Clinical Immunology·Wendy C MooreUNKNOWN National Heart, Lung, Blood Institute's Severe Asthma Research Program
Mar 7, 2009·The New England Journal of Medicine·Parameswaran NairPaul M O'Byrne
Oct 13, 2009·International Immunology·Taku Kouro, Kiyoshi Takatsu
Feb 16, 2010·The Journal of Allergy and Clinical Immunology·Eric D BatemanPaul M O'Byrne
Jun 2, 2010·The Journal of Allergy and Clinical Immunology·Roland KolbeckAnthony J Coyle
Mar 21, 2012·BMC Public Health·Teresa ToLouis-Philippe Boulet
Dec 18, 2013·The European Respiratory Journal·Kian Fan ChungW Gerald Teague
Jun 15, 2014·The Journal of Allergy and Clinical Immunology·Christopher NewbySalman Siddiqui
Sep 10, 2014·The New England Journal of Medicine·Elisabeth H BelUNKNOWN SIRIUS Investigators
Sep 12, 2015·The European Respiratory Journal·Dominick E ShawUNKNOWN U-BIOPRED Study Group
Oct 24, 2015·The Lancet. Respiratory Medicine·David B PriceIan D Pavord
May 24, 2016·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C J WalshJ G Martin
Jan 11, 2017·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Manali MukherjeeParameswaran Nair

❮ Previous
Next ❯

Citations

Jul 25, 2017·Expert Opinion on Drug Metabolism & Toxicology·Maria Gabriella MateraMario Cazzola
Feb 22, 2018·Drugs·A Markham
Apr 4, 2018·Expert Review of Clinical Immunology·Laurie A Manka, Michael E Wechsler
May 3, 2018·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Jonathan A Bernstein, Reynold Panettieri
Mar 27, 2018·Expert Review of Respiratory Medicine·Amir A Zeki, Mona Elbadawi-Sidhu
May 22, 2018·The New England Journal of Medicine·Klaus F RabeAriel Teper
Sep 16, 2017·American Journal of Respiratory and Critical Care Medicine·Manali MukherjeeParameswaran Nair
Oct 19, 2017·American Journal of Respiratory and Critical Care Medicine·Alberto PapiLeonardo M Fabbri
Jan 24, 2018·American Journal of Respiratory and Critical Care Medicine·Charlene M PrazmaEmilio Pizzichini
Apr 11, 2018·Journal of Leukocyte Biology·Matthew G DrakeZhenying Nie
Apr 8, 2018·Nature Reviews. Immunology·Peter J Barnes
Jun 26, 2018·Expert Opinion on Biological Therapy·Shiven S PatelJuan Carlos Cardet
Aug 9, 2018·Immunity, Inflammation and Disease·Keiji Oishi, Kazuto Matsunaga
Sep 21, 2018·Personalized Medicine·Deepak B Khatry
Nov 22, 2018·Current Opinion in Pulmonary Medicine·Ian D Pavord
Dec 5, 2018·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Khalid Al EfraijJ Mark FitzGerald
Dec 7, 2017·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Bao-Ping TianWei Cui
Dec 5, 2018·Expert Opinion on Investigational Drugs·Giancarlo MaroneGilda Varricchi
Nov 18, 2018·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Jocelyne JustFlore Amat
Nov 9, 2018·Current Opinion in Allergy and Clinical Immunology·Enrico HefflerGiorgio W Canonica
Dec 12, 2018·American Journal of Respiratory and Critical Care Medicine·Mary Clare McGregorMario Castro
Mar 14, 2018·ERJ Open Research·Eleftherios ZervasMina Gaga
Dec 2, 2017·The European Respiratory Journal·Arnaud BourdinPascal Chanez
May 19, 2018·The European Respiratory Journal·Athol U WellsUNKNOWN IPF Consensus Working Group
Feb 15, 2019·The European Respiratory Journal·Parameswaran Nair, Paul M O'Byrne
Aug 25, 2018·The European Respiratory Journal·Eugene R BleeckerJames G Zangrilli
Nov 18, 2018·The European Respiratory Journal·William W BusseGene Colice
Dec 20, 2017·Current Opinion in Allergy and Clinical Immunology·Jeffrey M ChamblissJulia W Tripple
Apr 4, 2019·The New England Journal of Medicine·Fei Li KuangAmy D Klion
May 2, 2018·Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology·Don HusereauAlain Gendron
May 21, 2019·Expert Opinion on Drug Metabolism & Toxicology·Luigino CalzettaPaola Rogliani
Feb 8, 2018·Allergy, Asthma & Immunology Research·Ji Ho LeeHae Sim Park
May 3, 2019·The European Respiratory Journal·Paul O'ByrnePeter Lange
Jun 7, 2019·Current Opinion in Allergy and Clinical Immunology·Sara M Assaf, Nicola A Hanania
Jul 4, 2019·Allergy·P Jane McDowell, Liam G Heaney
Jul 30, 2019·European Journal of Immunology·Lorenzo CosmiFrancesco Annunziato
Aug 8, 2019·Expert Review of Clinical Immunology·Enrico HefflerGiorgio Walter Canonica
Sep 5, 2019·Journal of Clinical Medicine·Agamemnon BakakosPetros Bakakos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.